Privia Health ROE 2020-2024 | PRVA
Privia Health ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2024-09-30 | $0.01B | $0.66B | 2.05% |
2024-06-30 | $0.02B | $0.64B | 2.43% |
2024-03-31 | $0.02B | $0.62B | 3.18% |
2023-12-31 | $0.02B | $0.61B | 3.96% |
2023-09-30 | $0.04B | $0.59B | 6.79% |
2023-06-30 | $0.03B | $0.57B | 6.36% |
2023-03-31 | $0.02B | $0.56B | 3.34% |
2022-12-31 | $-0.01B | $0.52B | -1.65% |
2022-09-30 | $-0.04B | $0.49B | -8.15% |
2022-06-30 | $-0.05B | $0.47B | -11.01% |
2022-03-31 | $-0.21B | $0.46B | -49.82% |
2021-12-31 | $-0.19B | $0.45B | -54.27% |
2021-09-30 | $-0.17B | $0.41B | -63.66% |
2021-06-30 | $-0.15B | $0.39B | -86.22% |
2021-03-31 | $0.03B | $0.15B | 42.32% |
2020-12-31 | $0.03B | $0.14B | 86.11% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $2.723B | $1.658B |
Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $38.872B | 57.28 |
Tempus AI (TEM) | United States | $10.232B | 0.00 |
Hims & Hers Health (HIMS) | United States | $8.842B | 224.83 |
Inspire Medical Systems (INSP) | United States | $5.430B | 169.35 |
IRhythm Technologies (IRTC) | United States | $3.397B | 0.00 |
Enovis (ENOV) | United States | $2.544B | 16.95 |
Azenta (AZTA) | United States | $2.469B | 114.98 |
Clover Health Investments (CLOV) | United States | $2.225B | 0.00 |
Schrodinger (SDGR) | United States | $1.886B | 0.00 |
Omnicell (OMCL) | United States | $1.826B | 39.83 |
10x Genomics (TXG) | United States | $1.773B | 0.00 |
Phreesia (PHR) | United States | $1.680B | 0.00 |
Butterfly Network (BFLY) | United States | $0.937B | 0.00 |
Talkspace (TALK) | United States | $0.608B | 0.00 |
Standard BioTools (LAB) | United States | $0.529B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.507B | 0.00 |
TruBridge (TBRG) | United States | $0.380B | 110.57 |
Nyxoah SA (NYXH) | Belgium | $0.369B | 0.00 |
Health Catalyst (HCAT) | United States | $0.334B | 0.00 |
Pulmonx (LUNG) | United States | $0.254B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
American Well (AMWL) | United States | $0.176B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.104B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.087B | 0.00 |
P3 Health Partners (PIII) | United States | $0.073B | 0.00 |
CareCloud (CCLD) | United States | $0.066B | 0.00 |
HeartBeam (BEAT) | United States | $0.065B | 0.00 |
111 (YI) | China | $0.057B | 0.00 |
Zepp Health (ZEPP) | China | $0.045B | 0.00 |
Outset Medical (OM) | United States | $0.043B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.043B | 0.00 |
Zhongchao (ZCMD) | China | $0.037B | 0.00 |
Movano (MOVE) | United States | $0.035B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
MSP Recovery (MSPR) | United States | $0.019B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.016B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
Syra Health (SYRA) | United States | $0.005B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |